Please Wait
Applying Filters...

List of NCGC00024678-03 Active Pharmaceutical Ingredient (API) suppliers/manufacturers & exporters

Menu
$ API Ref.Price (USD/KG) : 4,656Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Metrochem API Private Limited

02 1Lifecare Laboratories Pvt Ltd

03 1Pfizer CentreOne

04 1BrightGene Bio-Medical Technology Co.,Ltd

05 1DEAFARMA

06 1Fuan Pharmaceutical

07 1Hainan Poly Pharm

08 1Shenyang Syndy Pharmaceutical Co.,Ltd

09 1Sichuan Renan Pharmaceutical

10 1Teva API

11 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Nicergoline

About the Company :

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLifecare Labs has been developing innovative products in specialist areas of medicine.

Nicergoline

About the Company : Lifecare Labs specializes in producing bulk drugs (APIs) and intermediates that adhere to the industry's stringent quality parameters. Its objective is to deliver excellence throug...

Lifecare Labs specializes in producing bulk drugs (APIs) and intermediates that adhere to the industry's stringent quality parameters. Its objective is to deliver excellence through its "quality designed for excellence" mission and meet its customers' requirements. Cost-effectiveness is a top priority for the company, and it aims to establish long-term relationships with its clients. Lifecare Labs possesses state-of-the-art facilities for manufacturing bulk drugs (APIs) and intermediates and has dedicated units for products. Its mission is to become a globally recognized company responsible for its customers, business partners and society.
LifeCare Laboratories

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.

Nicergoline

About the Company : Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
...

Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates. Backed by Pfizer resources, we’ve been delivering technical expertise, regulatory support and long-term supply for over 40 years. With 35+ sites across six continents, our expansive network allows us to securely and efficiently guide complex compounds from development through commercial manufacture. For more information, visit http://www.pfizercentreone.com
Pfizer centreOne

04

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special gener...

BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.
blank

05

DEAFARMA

Italy
AAPS 2024
Not Confirmed
arrow

DEAFARMA

Italy
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.
blank

06

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an a...

Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an area of about 100 acres, a construction area of over 30,000 square meters, and a registered capital of 1.189 billion yuan. It is the first company in Changshou Economic and Technological Development Zone successfully listed on the Shenzhen GEM (March 22, 2011, stock code: 300194). The company has 9 wholly-owned and holding subsidiaries. In March 2008, Fuan Pharmaceutical Group Chongqing Lybon Pharm-Tech Co
blank

07

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : Hainan Poly Pharm. Co., Ltd. (Poly Pharm, stock code: 300630), founded in 1992, is a high-tech enterprise specialized in the research and development, production, and sales of gene...

Hainan Poly Pharm. Co., Ltd. (Poly Pharm, stock code: 300630), founded in 1992, is a high-tech enterprise specialized in the research and development, production, and sales of generic drugs and innovative drugs. It is one of the few domestic pharmaceutical formulation companies with internationalization as its leading strategy. It produces antipyretic analgesics, injections, digestive drugs, and antibiotics, among others. The company products include azithromycin, ganciclovir sodium, levetiracetam, pantoprazole sodium, and eptifibatide.
blank

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : Shenyang Syndy Pharamaceutical Co.,Ltd..mainly engage in R&D of chemical drugs and function chemicals synthesis. We have been successful in synthesis of chlorphenamine, dexbromphen...

Shenyang Syndy Pharamaceutical Co.,Ltd..mainly engage in R&D of chemical drugs and function chemicals synthesis. We have been successful in synthesis of chlorphenamine, dexbromphenamin , bepotastine, lorartadine in new way and function chemicals such as OLED material etc. We mainly produce chlorphenamine maleate under GMP approved by SDA of China and offer with CP2000 \ BP2000 \ USP24\JP14\EP2000. The scale is largest in Asia. We are the only Manufacturer of Dexchlorpheniramine Maleate in China, supplier for Japan 15 years. We received IVB for products Dexchlorpheniramine Maleate and Brompheniramine maleate in Oct 2018.
blank

09

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : Sichuan Renan Pharmaceutical Co., Ltd., founded in June 2013 with 325 acres and more than 1000 employees , located in Yuechi Pharmaceutical Industrial Park, Guangan city Sichuan pr...

Sichuan Renan Pharmaceutical Co., Ltd., founded in June 2013 with 325 acres and more than 1000 employees , located in Yuechi Pharmaceutical Industrial Park, Guangan city Sichuan province,China , is a wholly-owned subsidiary of Chengdu Brilliant Pharmaceutical Co., Ltd group. Renan Pharma is PMDA and EU approved , it is a high-tech innovative enterprise committed to the research & development, producing and sales of high-tech APIs and intermediates for global.
blank

10

Teva API

Israel
AAPS 2024
Not Confirmed
arrow

Teva API

Israel
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : Teva API is a standalone business unit within Teva Pharmaceutical Industries, the world’s largest generic drug manufacturer. Employing over 4,000 professionals at 15 internationa...

Teva API is a standalone business unit within Teva Pharmaceutical Industries, the world’s largest generic drug manufacturer. Employing over 4,000 professionals at 15 international plant sites and 6 R&D centers, Teva API is a leading international supplier of active pharmaceutical ingredients (APIs) with the industry’s broadest portfolio of over 350 products. Its leadership in cutting-edge development, large-scale production capacity and global support make it an ideal API partner of choice. Over its more than 85 years of existence, Teva API has acquired and established top-rated manufacturing and development facilities around the world.
blank

11

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Nicergoline

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank

NCGC00024678-03 Manufacturers | Traders | Suppliers

NCGC00024678-03 Manufacturers, Traders, Suppliers 1